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Abstract
The ADI as a tool for risk management and regulation of food additives and pesticide residues is not readily applicable to
inherent food plant toxicants: The margin between actual intake and potentially toxic levels is often small; application of the
default uncertainty factors used to derive ADI values, particularly when extrapolating from animal data, would prohibit the
utilisation of the food, which may have an overall beneficial health effect. Levels of inherent toxicants are difficult to control; their
complete removal is not always wanted, due to their function for the plant or for human health. The health impact of the inherent
toxicant is often modified by factors in the food, e.g. the bioavailability from the matrix and interaction with other inherent
constituents. Risk-benefit analysis should be made for different consumption scenarios, without the use of uncertainty factors.
Crucial in this approach is analysis of the toxicity of the whole foodstuff. The relationship between the whole foodstuff and the
pure toxicant is expressed in the ‘product correction factor’ (PCF). Investigations in humans are essential so that biomarkers of
exposure and for effect can be used to analyse the difference between animals and humans and between the food and the pure
toxicant. A grid of the variables characterising toxicity is proposed, showing their inter-relationships. A flow diagram for risk
estimate is provided, using both toxicological and epidemiological studies. © 1998 Elsevier Science B.V. All rights reserved.
Keywords: Risk assessment; Inherent food plant toxicants; Natural toxins; Whole foodstuff toxicity
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1. Introduction
Traditional foods are supposed to be safe on the
basis of long term experience, even though these foods
may contain inherent toxicants and anti-nutritional
substances. For considering the safety of food derived
from biotechnology, the OECD (1993) described its
concept of food safety based on long-term experience:
‘The safety of food for human consumption is based on
the concept that there should be a reasonable certainty
that no harm will result from intended uses under the
anticipated uses of consumption. [...] In principle, food
is presumed to be safe unless a significant hazard has
been identified.’ The OECD concept relates to the past
understanding of risk and health demands. However,
contemporary advances in analytical techniques and
our growing knowledge of long-term effects and effects
from chronic exposure make it possible to detect health
effects which were previously unrecognised. Further-
more, our standard of living, life expectancy and health
perception have changed considerably over the past few
decades. This includes cultural changes in diets of con-
sumers, with trends such as organic, vegetarian, exotic,
minimally processed and fast foods. This all necessitates
reviewing the previously considered safety of products
against the present situation.
The desire to breed for plant resistance, combined
with new biological techniques that may produce dras-
tic alterations of plant metabolite levels, as well as new
food processing methods, have resulted in the develop-
ment of new plant food commodities. In the evaluation
procedures for novel food plants and products thereof,
the demonstration of substantial equivalence to an ex-
isting plant or product is a corner stone. In this context,
inherent food plant toxicants are important substances
to be selected for this comparison of equivalence. These
new opportunities for both the enhancement as well as
the reduction of plant metabolites also raise questions
as to the desirability or necessity to alter them. For
some substances it may therefore be necessary to evalu-
ate the possible risks and, possibly, to set limits.
An important question is whether food plant toxi-
cants should be treated differently from man-made
chemicals in risk assessment and regulation. In 1995 the
US Committee on Comparative Toxicity of Naturally
Occurring Carcinogens (National Research Council,
1996) concluded, after assessing the relative potency of
over 200 carcinogens of which 65 occurred naturally,
that there is no notable mechanistic or potency differ-
ence between synthetic and the known naturally occur-
ring carcinogens in the human diet. The Committee
then concluded that both naturally occurring and syn-
thetic chemicals can be evaluated by the same epidemi-
ology or experimental methods and procedures.
However, the above mentioned approach is inappro-
priate in most cases for inherent food plant toxicants,
as it does not take into consideration the accompanying
toxicity-modulating food factors such as possible health
beneficial constituents, matrix effects, or the overall
health benefit of the food.
The main objective of this paper is to discuss the
appropriateness of applying the current methods in risk
assessment as a basis for risk management and regula-
tion in this context, and a more appropriate approach
for inherent plant toxicants is proposed.
Inherent food plant toxicants are plant constituents
which might give rise to adverse effects in humans when
the plant or plant products are ingested. This definition
was originally adopted by EU-AIR-NETTOX in 1996
(Gry et al., 1998) and it is comparable with the defini-
tion by the USA Food and Drug Administration: a
naturally occurring poisonous or deleterious substance
is an inherent natural constituent of a food which is not
the result of environmental, agricultural, industrial, or
other contamination (Ely, 1989).
Anti-nutritional factors are food components that
diminish or inhibit the adequate utilisation of specific
nutrients. In general these constituents are not toxic
themselves, but limit the bioavailability of nutrients.
These anti-nutritional factors are not taken into consid-
eration in the present document.
1.1. Role of inherent toxicants in the plant
Inherent plant toxicants are among the plant metabo-
lites which are claimed to have an ecological role in the
physiology, proliferation or defense of plants. Although
some constituents seem to be designed to deter feeding
by mammals, which are thus toxic or otherwise un-
pleasant to humans, several constituents with possibly
other purposes (plant physiological, defense against
insects, bacteria, fungi and viruses) may also just hap-
pen to be toxic to humans (Harborne, 1988). Of most
substances, however, their precise function for plant
health and proliferation is not known. This makes
modifying their levels in plants in the pursuit of min-
imising risks of food poisoning a delicate matter.
Some of these constituents are allellopatics or phy-
toalexins. Induction of many of such inherent toxicants
can result from a plant’s exposure to many kinds of
elicitors, e.g. bacterial infection, viruses, exposure to
cell wall fragments, cold, UV light, heavy metal salts,
antibiotics, fungicides, herbicides and at feeding sites of
nematodes (Beier, 1990).
1.2. Health protecting and ad6erse effects
Several plant constituents may have certain positive
health effects under some conditions, and adverse ef-
fects under others. An example of this is the apparent
oestrogen agonistic or antagonistic effect of plant
oestrogens such as isoflavones in soybean. Neonatal
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soy-genistein administration prevented mammary can-
cer in rats (Lamartiniere et al., 1995). Associations have
been found between soybean consumption and reduced
breast cancer in women, and consequently, claims of
breast cancer prevention have been made (Adlercreutz
and Mazur, 1997). On the other hand, neonatal expo-
sure to phytoestrogen diets altered the uterus weight in
female rats, as well as the neuroendocrine development
in both male and female rats (Whitten et al., 1993,
1994; Medlock et al., 1995; Whitten et al., 1995). The
type of effects may depend upon the phytoestrogen
type, dosage, timing, duration and pattern of exposure
and the age of the consumer. The high exposure of
infants to phytoestrogens from soy-based infant for-
mula is likely to exert biological effects (Setchell et al.,
1997).
Another example is the flavonoid quercetin which, in
experimental studies has been shown to have carcino-
genic effects (Zhu and Liehr, 1994) and to be an
anti-carcinogen (Deschner et al., 1991; Scambia et al.,
1991), while epidemiological studies indicate protection
against cardiovascular diseases (Hertog, 1994). Certain
glucosinolates may affect thyroid, liver, and kidney
function, while some metabolites of glucosinolates have
been shown to activate mechanisms which moderate or
reverse carcinogenic processes (Heaney and Fenwick,
1995).
After reviewing the literature on cruciferous plants,
Beier (1990) concludes that the glucosinolate degrada-
tion product indole-3-carbinol (I3C) isolated from
Brassica oleracea given before a carcinogen, protects
against carcinogenesis, whereas, when given after a
carcinogen, it strongly promotes carcinogenesis. Sub-
stances which alter the microsomal mixed-function oxi-
dase enzyme system may increase the detoxification of
some carcinogens but enhance the neoplastic response
under other conditions (Wattenberg, 1979; De Flora et
al., 1991).
Of a number of naturally occurring organic sub-
stances their capacity to prevent the neoplastic effects
of chemical carcinogens has been demonstrated in ex-
perimental studies (Wattenberg, 1979; De Flora et al.,
1991). Current activities are especially focused on the
following groups of constituents: glucosinolate degra-
dation products, flavonoids, carotenoids, simple cou-
marins, terpenoids, cystein sulphoxide degradation
products, curcuminoids and cinnamic acid derivatives.
These compounds may also poses a toxic potential. It is
likely also that other inhibitors are present in natural
products.
Saponins are usually classified as inherent food plant
toxicants. Recently it was found that soybean saponins
in mice prevented the induction of preneoplastic
changes in the colon (Koratkar and Rao, 1997). The
authors suggested that soybean saponins might play a
significant role as chemotherapeutic substances in the
management of colon carcinogenesis.
Reduction of the anti-nutritional factor phytic acid in
the human diet has been advocated in order to counter-
act the problems of mineral availability (Liener, 1980),
while others refer to the potential role of phytate in
reducing colon cancer and plead for it to remain
(Messina, 1992).
Apart from the essential nutrients, there is no hard
proof (yet) that other food constituents have a benefi-
cial net effect, but their possible positive effect on
health should not be ignored.
In cases where the necessity of a constituent has not
been proven and as long as the substance has been
shown to produce adverse effects in well performed
experiments, it seems prudent to consider the adverse,
rather than the possible health promoting effects, for
risk assessment. However, the margin between the lev-
els which result in positive or negative health effects,
respectively, as well as intake in the population, should
be established before intake levels are regulated. Last
but not least, care should be taken with the extrapola-
tion from high-dose experiments in animals to real
intake levels in humans, while the net effect of the food
product on the uptake and metabolisation of the com-
pound, as discussed below, is critical in the evaluation.
2. The basis for risk management and regulation of
food additives and contaminants
2.1. Types of toxicity and risk assessment
Toxic effects may be divided into two broad types,
deterministic and stochastic. Deterministic effects typi-
cally increase in severity with increase in dose, and so
show a dose-dependent frequency distribution in the
exposed population; typically, a threshold dose exists
below which an effect is not produced. Most toxic
effects are deterministic. Stochastic effects show an
increase in incidence with increase in dose, but the
severity of the effect is largely independent of dose.
Stochastic effects, such as the effect of a genotoxic
carcinogen, are considered not to show a threshold
dose. Therefore, the higher the dose, the more likely it
is that an individual will show the adverse effect (IPCS,
1994).
Traditionally, different approaches have been
adopted in order to ensure human safety. For determin-
istic effects, the NOEL (no-observed effect level) has
been used as a surrogate for the threshold for toxicity
with uncertainty factors used to determine an accept-
able daily intake (ADI) or tolerable daily intake (TDI)
(see below). For stochastic effects risk assessment has
either used a mathematical model, such as linear, multi-
stage model, to predict the dose associated with a
specified low risk (e.g. 1 in 106 lifetimes) or the absence
of a threshold has been used as a basis for recommen-
A.J.A. Essers et al. : En6ironmental Toxicology and Pharmacology 5 (1998) 155–172158
dation of a reduction in exposure to the lowest level
technologically possible. Dose-response extrapolation
outside the range of the experimental data is critically
dependent on the mathematical model used; uncertainty
increases and precision decreases, the further the risk
estimate is from the experimental range.
2.2. The ADI concept, history and definition
The Joint FAO:WHO Expert Committee on Food
Additives (JECFA) met for the first time in 1956 to
consider the safety of food additives. During the first
few meetings the concept of the acceptable daily intake
(ADI) was developed, which was adopted by the Com-
mittee in 1961. The ADI is derived from a no-observed-
effect-level (NOEL) to which a safety factor is applied
(FAO:WHO, 1958). In scaling from experimental ani-
mals to humans, JECFA has based the relationship on
body weight, and the ADI is expressed in terms of
mg:kg body weight per day.
JECFA continues to establish ADIs for food addi-
tives and veterinary drugs. Likewise, the Joint FAO:
WHO Meeting on Pesticide Residues (JMPR)
establishes ADIs for pesticides. JECFA uses the same
approach for contaminants that exhibit a threshold of
toxicity, although other terminology that employs the
concept ‘tolerable’ rather than ‘acceptable’ is used
The ADI has been defined (FAO:WHO, 1991) as ‘‘an
estimate of the amount of a substance in food or drinking
water, expressed on a body-weight basis, that can be
ingested daily o6er a lifetime without appreciable health
risk (standard human60 kg).’’
Regulations or international standards for chemicals
in food should be established in such a way that the
ADI is not exceeded when the regulation or standard is
met. Both JECFA and JMPR express the ADI in a
range, from zero to its numerical value. The purpose is
to emphasise that no more of a food additive should be
used than necessary to achieve its desirable technologi-
cal effect (Good Manufacturing Practice) or of a pesti-
cide or veterinary drug than is necessary under Good
Agricultural Practice or Good Practice in the Use of
Veterinary Drugs, respectively. This is known as the
ALARA principle, as low as reasonably achie6able.
The ADI is based on the weight of evidence ap-
proach in that all available information is considered in
its establishment. The NOEL that is used as the basis
for the ADI is usually the highest one for the critical
effect in the most sensitive species (IPCS, 1994). When
evaluating toxicological data it is not always obvious
whether the effects that are observed are adverse. This
is particularly true with food additives where reductions
in body weight are often observed. JECFA usually
takes the conservative approach that an effect should
be considered adverse in the absence of information to
the contrary and should serve as the basis for the ADI.
With pesticides, the effects observed are nearly always
adverse, so the term ‘no-observed-adverse-effect-level
(NOAEL)’ is used.
The NOAEL is not a precise indication of the
threshold level dose at which toxic effects occur in the
test animals. The NOAEL depends on the background
incidence of the effect, the sensitivity of the measure-
ment, the spacing of the doses and the size of the
group. An alternative starting point for risk assessment
is the benchmark dose (BMD), which is the 95th per-
cent lower confidence limit of the dose producing a 1, 5
or 10% response determined by dose-response mod-
elling (Barnes et al., 1995). The BMD makes greater use
of the dose-response data but, like the NOAEL, it does
not address the uncertainties of inter-species differences
or inter-individual variability in the human population,
nor the extrapolation from high to low dose.
The ADI is based on data from toxicity:safety studies
in animals, or humans when available. The NOAEL
derived from the studies is divided by a safety or
uncertainty factor to allow for any species differences in
susceptibility, the numerical differences between the test
animals and the human population exposed to the hazard,
the greater 6ariety of complicated disease processes in the
human population, the difficulty of estimating the human
intake and the possibility of synergistic actions among
food additi6es (IPCS, 1987). In practice a factor of 100
is usually applied to the NOAEL from animal studies
and ten to the data from human studies. In conse-
quence the factor of 100 is regarded as comprising two
factors of ten; one ten-fold factor to allow for inter-spe-
cies differences and the other ten-fold factor to allow,
primarily, for human variability. These factors are ap-
plied to the external dose (mg:kg bw:day) and allow for
uncertainties in both kinetics (delivery to the target site)
and dynamics (sensitivity of the target site to the chem-
ical delivered via the circulation for systemic toxicity).
Thus the interspecies factor is to allow for undefined,
possible differences between the test animal and hu-
mans and the inter-individual factor is to allow for
undefined possible variability between humans (Ren-
wick, 1991).
Reviewing the adequacy of the 1010 safety factor,
Renwick (1991) concluded that the 100-fold safety fac-
tor is difficult to justify on theoretical grounds, but it
remains a pragmatic solution to the interpretation of
animal data. This seems to be a generally accepted view
among toxicologists.
It has been proposed that each ten-fold uncertainty
should be further subdivided into toxicokinetic and
toxicodynamic aspects, so that chemical specific data
could be incorporated into the risk assessment in order
to replace a default uncertainty factor by relevant data
(Renwick, 1993). This concept was discussed at a WHO
Task Group meeting (IPCS, 1994), which concluded
that the ten-fold factor for species differences could be
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considered to comprise four-fold for kinetic aspects and
2.5-fold for dynamics, and that the ten-fold factor for
interindividual differences could be considered as com-
prise two equal factors (3.16 * 3.16). This reconsider-
ation of the role of the 100-fold uncertainty factor
provides a mechanism for the incorporation of the
results of recent progress in toxicology, such as toxi-
cokinetics, mechanisms of toxicity, Pharmacologically
Based Pharmaco Kinetic (PB-PK) modelling, in vitro
data and biomarkers of exposure or effect. Elucidation
of the kinetics and mechanisms of toxicity will help to
improve the extrapolation of results from high dose
experiments in rodents or in vitro systems to estimates
of risk associated with low dose exposure in the human
situation. This helps in species selection and the devel-
opment of biomarkers. Similar knowledge is also im-
portant in the risk assessment of food plant toxicants as
described in detail below.
The concept of the ADI is a generally accepted and
widely adopted system to protect the population from
potential adverse effects of food additives and pesticide
residues. However, the use of a large factor to allow for
the uncertainties of inter-species and inter-individual
differences may not be appropriate to considerations of
an inherent toxicant present in a plant food.
3. Safety evaluation and regulation of inherent food
plant toxicants—problems with the application of the
ADI concept for evaluating inherent food plant
toxicants
ADI’s have not been established for most inherent
food plant toxicants, because no NOAEL values have
yet been established in animal models, because of the
vast number of substances in plants and the lack of
economic stimulus to do so. A complicating factor is
that some inherent food plant toxicants, in addition to
their adverse effects, may exercise health protecting
effects, depending on the dosage, the target organ and
the consumer’s physical condition and age. Also, the
presence of other factors, contained in the same food,
may greatly influence the possible effects. The ADI is
established at a value at which effects are very unlikely
to occur in humans. The default options (i.e. usual
assumptions made in the interpretation of toxicological
data) are generally viewed as providing a ‘conservative
estimate’ of risk; that is, their use is likely to overesti-
mate the true risk. Because the ADI is applied to
substances that are added to food, safety can be en-
sured by limiting levels of use or by prohibiting those
substances.
The margin of safety between the intake of inherent
food plant toxicants and the appearance of toxic effects
is often quite low. Their removal is not always desir-
able, due to their possible function in the plant’s physi-
ology, proliferation or defence, and as they are
sometimes linked to desired organoleptic traits of the
food. Also for some substances, such as micro nutri-
ents, an intake slightly below a toxic one may be
beneficial for some health aspects. The use of standard
uncertainty factors would limit the intake of the plant
material to such a low level that the use of the food
would, in practice, be prohibited. Thus, risk:benefit
decisions must be made.
The risk manager ultimately must decide, for exam-
ple, which population groups are most ‘at risk’, whether
the food supply is sufficient to limit a particular
product, and which percent of the population should be
covered. Because the putative risks from inherent food
plant toxicants are not zero, the risk should be fully
described and, in most cases, provided in a range so
that the risk manager can compare risks. This is partic-
ularly important at the international level where assess-
ment advice is used for managing risks under varying
economic and cultural conditions.
When the inherent food plant toxicant provides a
beneficial effect at certain dietary levels, this should also
be assessed, and a characterisation of risk:benefit
should be provided. So, the strategy to avoid a priori
any appreciable risk cannot be maintained for all inher-
ent food plant toxicants. There is some similarity with
nutrients.
For some nutrients the margin between the generally
ingested amount or physiologically required dose and
the maximal safe dose is narrow. For example, the
amino acids methionine, phenylalanine and leucine are
essential for body growth and maintenance, but in the
rat the adverse effect level in mg:kg body weight is only
3–4 times the nutritional requirement in man (IFBC,
1990). Considering the essential amino acids only from
a toxicological point of view, using a common safety
factor of 100, or even of ten, would be detrimental for
human nutrition. For vitamin A (retinol equivalent) the
recommended intake in, potentially, pregnant women is
1 mg:day, the maximum safe level of daily intake is
estimated at 3 mg, and teratogenic effects of retinol as
vitamin A supplement have been observed at a daily
intake of 7.5 mg:day (Rothman et al., 1995). The
precise intake associated with abnormalities has not
been defined (Oakley and Erickson, 1995; Mills et al.,
1997). For energy intake the margin is possibly just a
few percent. Over consumption of energy is considered
to be the highest food born carcinogenic factor (Na-
tional Research Council, 1996). Renwick (1991) calcu-
lated from literature the factor between normal human
daily intake per body weight and the daily intake
associated with toxicity for a number of food con-
stituents. Application of usual uncertainty factors
would result in levels that are inadequate for nutritional
requirements.
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The suspected carcinogenicity of selenium in animal
experiments cannot result in regulatory actions for an
absolute reduction of human exposure. Indeed, sele-
nium is now considered to be an essential element and
at low doses it even functions as an anti-carcinogen. So,
for essential food constituents the simplified use of a
safety factor is inappropriate: more toxicological, epi-
demiological and nutritional research is needed to re-
duce uncertainties where recommended intake levels
and safety limits on both sides need to be balanced.
3.1. Matrix effects and interaction with other
constituents
The bioavailability, kinetics and thus toxicity of the
pure food plant toxicant or its active metabolite may be
very different from when it is ingested in its common
food matrix. Examples of such differences in bioactivity
associated with different bioavailabilities due to matrix
effects and by interaction with other food constituents
are the following:
About 600 naturally occurring carotenoids are
known. It has been found that the low and variable
bioavailability of carotenoids from plant foods depends
strongly upon the specific compound, the molecular
linkage, the amount consumed in a meal, the matrix in
which the carotenoid is incorporated, absorption
modifiers, nutrient status of the host, genetic and other
host related factors, and interactions between these
factors (De Pee and West, 1996). The matrix in which
b-carotene is embedded is a very important determi-
nant of its bioavailability. b-Carotene may be or-
ganised in pigment-protein complexes which are located
in cell chloroplasts, or it may be located in the chromo-
plasts of cells, often in lipid droplets. Cells of the plant
first need to be disrupted in order to free b-carotene
from its matrix. Secondly, the chloroplast or chromo-
plast needs to be accessed, and thirdly the b-carotene
molecule, if bound, has to be separated from its ligand.
Releasing b-carotene from a pigment-protein complex
would be more difficult than freeing it from a lipid
droplet (De Pee and West, 1996). Food processing,
such as reducing particle size and heating, may reduce
matrix effects and increase the bioavailability.
The cyanogen content of cassava flour in Africa
usually grossly exceeds the safety limit set by the Codex
Alimentarius (Essers, 1998), but toxic effects are rare
under normal conditions. This can be explained partly
because the cyanogens are mainly bound in glucosides
which are relatively stable in the human body: in exper-
iments with human volunteers less than 50% of the
cyanogenic glucoside intake was found to be degraded
to HCN (Carlsson et al., 1995). Also important is the
form in which the product is consumed: cassava flour is
prepared into a stiff paste, which forms an elastic ball
in the stomach and reduces in size only very slowly.
This causes a slow release of the toxicant, which can
then be detoxified more effectively by the body’s de-
fence mechanism than would occur after acute exposure
(Schultz, 1984). Thus, the food matrix, which can be
manipulated by processing and preparation, is an im-
portant factor in determining the bioavailability.
Indole I3A, isolated from green cabbage, forms di-
rectly mutagenic N-nitroso compounds upon treatment
with nitrite, but not when in the presence of the juice of
green cabbage. In consequence, the contribution of I3A
to the total mutagenicity of nitrite treated Brassica was
marginal (Tiedink, 1991). A recent review of epidemio-
logical studies also suggested that consumption of Bras-
sica vegetables is associated with a decreased risk of
cancer, notably colon, rectum, stomach and lung cancer
(Verhoeven et al., 1996). This net beneficial effect shows
that the adverse effect of one component can be neu-
tralised and even overruled by a positive effect from
other components in the same plant food.
Heated apple juice contains both mutagenic and anti-
mutagenic compounds, whereby the latter can neu-
tralise the former ones. When fractionated, one fraction
obtained from gel filtration of heated clear apple juice
showed a dose-related mutagenic response, while whole
heated clear apple juice did not. Apple juice samples
caused a reduction in the mutagenic activity of the
known mutagens NQO and MNNG in the Salmonella
mutagenicity assay (Ekasari, 1989).
Based on mechanistic studies, carcinogenicity from
nitrate plus amides, through conversion to ni-
trosamines, is suspected by some researchers. However,
vitamin C present in vegetables, which are also a major
dietary source of nitrate, has been shown to inhibit
N-nitroso product formation by chemically reducing
nitrous acid (Mirvish, 1983). Vegetable consumption is
associated rather with a lower incidence of cancer
(Steinmetz and Potter, 1991a,b).
In general, plant foods can be regarded as complex
mixtures of which the composition varies between cer-
tain physiological limits. The adverse effect of one
substance may be enhanced, supplemented or neu-
tralised by others. The interaction of the plant toxicant
with the food can be made by anti-oxidants, anti-muta-
gens, specific anti-toxicants, spatial or functional hin-
drance, or other factors that influence the kinetics of
the ingested toxicant.
3.2. Balancing inherent food plant toxicants and health
protecting constituents in food?
There is an argument for balancing the toxicant with
the neutralising or otherwise health protective effect of
the foodstuff in which the toxicant is contained. We
suggest that this may only be considered when the
protection factor is as inherent to the particular food as
the toxicant and a reduced toxicity has been shown
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either experimentally or by epidemiology. However,
balancing the separate health effects of individual food
constituents is a complex task. Apart from the immense
number of constituents in food to balance, one cannot
simply add known effects of each constituent in order
to calculate a net health effect since this would omit
any interactions that may take place.
Then how can one judge the quality of the plant-food
product in relation to the presence of potential inherent
food plant toxicants and of neutralising or otherwise
health-promoting factors? Part of the solution might lie
in attributing higher value to the toxicity (and testing)
of the whole foodstuff, rather than the isolated sub-
stances. This more holistic approach is justified because
the resultant toxicity of the foodstuff does not equal the
sum of the effects of its constituents, and the number of
constituents and possible influencing factors is too large
to be studied individually. The suspected risk of single
food plant toxicants should be verified by whole food-
stuff testing. This will then help in establishing limits
for specific constituents, if found necessary. Where
cases of toxicity have been found with the whole food
stuff, these data should be complemented by toxicody-
namic and toxicokinetic data from studies of single
substances and mixtures of some of the relevant
constituents.
For subsequent risk management and regulation,
consideration may be necessary between the benefits
and adverse effects of alternatives, such as plant-con-
tained inherent pesticides versus industrial pesticides,
which probably can only be done on a case by case
basis.
4. Regulatory aspects of inherent plant toxicants
4.1. Considerations from other institutions
The US Food and Drug Administration (FDA)
utilises an approach for natural toxicants in ‘traditional
foods’, based on the Food, Drug and Cosmetics (FD
and C) Act, Section 402(a)(1), which is distinct from
that for additives. If the poisonous or deleterious sub-
stance is a normal component of that food and not an
‘added’ substance, the food is prohibited from sale only
if the quantity of such substance in the food ‘ordinarily
renders the food injurious to health’ (Flamm et al.,
1994). The US Congress instructed FDA to pay less
attention to ingredients that had been in use for many
years without observable adverse effects (Merrill, 1991).
There appear to be two different safety standards,
depending on whether the poisonous or deleterious
substance is added or is a normal component of food.
Traditional food was presumed to be safe, and for it to
be found unsafe, it must have demonstrably affected
the health of consumers of that food (Flamm et al.,
1994). This seems to imply 1) that the effect of possibly
toxic substances in traditional foods should not be
considered separately, but only in relation to the whole
diet, and 2) that data are required from observational
population studies.
As mentioned earlier, the US Committee on Compar-
ative Toxicity of Naturally Occurring Carcinogens (Na-
tional Research Council, 1996) concluded that both
naturally occurring and synthetic chemicals can be eval-
uated by the same epidemiology or experimental meth-
ods and procedures. This seems to conflict with the
implications of Section 402(a)(1).
Regarding regulation of naturally occurring toxins,
the US FDA has interpreted FD and C Act Section 406
as permitting a balancing of the value of the food, the
toxicity of the contaminant, and the feasibility of reduc-
ing or eliminating the contaminant. It concerns sub-
stances that have been historically acceptable to
consumers, which often provide significant benefits, and
are disproportionately difficult to avoid or remove (Ely,
1989).
4.2. Classification and priority setting of known
inherent food plant toxicants
Plants are made up of many thousands of substances,
most of which have not been subjected to toxicological
research. An example of the vast number of bioactive
substances in food plants is that 96 bioactive substances
have already been identified in basil (Beier, 1990). The
known inherent food plant toxicants can be classified in
several categories, relating to their plant source, the
chemical structure of the substance or its physiologi-
cally active metabolite, or to the mode of action.
Overviews of known inherent food plant toxicants are
given by Duke (1977), Liener (1980), Concon (1988),
Cheeke (1989), Beier (1990), IFBC (1990), D’Mello et
al. (1991), IPCS and ILSI Europe (1992. 1992) distin-
guished coumarins, cyanogens, cycasin, dioscorea alka-
loids, furocoumarins, glucosinolates, glycoalkaloids,
glyzrrhizin, haemagglutinins, hydrazines, hydrazones,
isoflavones, lupin alkaloids, methylene dioxybenzenes,
methylxanthines, pyrrolizidin alkaloids, saponins, tan-
nins, toxic aminoacids, toxic fatty acids, vicine and
convicine.
Priorities for research and evaluation of inherent
plant toxicants have recently been proposed by IPCS
and ILSI Europe (1992). The priority setting was based
upon the following criteria:
1. The available toxicity data indicate chronic, rather
than acute, effects.
2. High exposure to humans, including certain risk
groups.
3. Insufficient experimental data and:or lack of ade-
quate risk evaluation.
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The regional importance of the crop or regional
exposure levels are also used for establishing priorities.
Inherent toxicants from several plant source materials,
including food plants, herbs and spices, are regulated
according to the EU Council Directive on Flavourings
(88:388:EU), eg. coumarin, safrole, thujonie and hydro-
cyanic acid (originating from cyanogenic glycosides).
Very few other regulatory measures have been taken in
this field. In contrast to food additives, there is hardly
any direct economic stimulus to undertake comprehen-
sive toxicological tests with inherent food plant toxicants.
Speijers (1995) observed a vicious circle in the lack of data
on their occurrence and toxicology: as long as nobody
is made responsible for studying safety aspects of inherent
plant toxicants, the lack of data will persist, and regula-
tion based on thorough toxicological studies will remain
absent. In rare instances, acute toxicity data are available
from exposed humans (e.g. acute poisonings among
mushroom-eaters). Observational epidemiological stud-
ies may provide data on long-term (chronic) health effects
(such as the effects of xeno-oestrogens from dietary
plants), which can be critically important for the risk
assessment. However, in the majority of situations, direct
human data are not available, and the potential risks must
be predicted from experimental data.
To break the circle and make progress, Speijers suggests
that at least some regulation is needed to create a demand
for toxicological studies or to stimulate the quality of such
studies. However, this may give another problem because
even when data exist, it is often not clear on what grounds
such regulation should be based.
Impetus towards regulatory action may be gained by
the development of new biological breeding tools, which
allow inherent food plant toxicant levels, as well as the
factors that may modify their bioavailability, to be
altered.
Examples of inherent food plant toxicants which have
been subjected to some kind of regulation are the
following.
4.2.1. Solanum glycoalkaloids (SG)
The product requirement for total glycoalkaloid con-
tent often found in literature is 200 mg:kg potato as ‘safe
limit’ or ‘upper safety limit’ (Morris and Petermann,
1985). This may have been established on the basis of
acute toxic effects being found in humans consuming
potato solanine levels of 257 mg:kg and higher, and no
acute toxic effects being seen after consumption of
tubers with 196 mg:kg potato (Griebel, 1923; Bo¨mer and
Mattis, 1924, in: Van Gelder, 1989). Bo¨mer and Mattis
concluded that potatoes with a solanine content exceed-
ing 200 mg:kg seem to cause adverse effects on human
health. It is not clear whether the potatoes had been
eaten with or without peel. Also the methodology for
assessing glycoalkaloids in the old studies add uncer-
tainty.
The Nordic Working Group on Food Toxicology and
Risk Assessment (1991) suggested the following argu-
ment for regulation: The LOEL for SG in man is 2
mg:kg bw:day. Based on an estimated average daily
intake of 300 g potatoes the limit of 200 mg:kg potatoes
would correspond to 1 mg SG:kg bw:day in adults.
Peeling causes two-thirds loss of SG, leading to 0.3
mg:kg bw:day. They suggest that a safety margin of a
factor 2–6 exists, but also stress that higher potato
consumption occurs, and that 8% of the early potatoes
in Sweden contained \200 mg:kg potato. They con-
clude that the safety margin for ‘solanine’ cannot be
considered satisfactory. They recommend that 200 mg:
kg should be the maximum acceptable level for potato
varieties currently available on the Nordic market, and
that efforts should be made to reduce the levels of SG;
The SG levels in new potato varieties should not exceed
100 mg:kg.
In The Netherlands, the potato producers (‘Com-
missie voor de samenstelling van de rassenlijst and
Productschap voor Aardappelen’) made an agreement
(‘convenant’) among themselves to observe a limit of 100
mg:kg fresh weight for new potato cultivars (Bal, 1989).
4.2.2. Pyrrolizidine alkaloids
After an extensive study on pyrrolizidine alkaloids,
IPCS (1988) concluded that ‘Because of their known
involvement in human poisoning and their possible
carcinogenicity, exposure to pyrrolizidine alkaloids
should be kept as low as practically achievable. The
setting of regulatory tolerance levels for certain food
products may be required in some situations.’ The
control of plant populations for preventing poisoning in
man was carried out only in Uzbekistan, following the
epidemics of human disease due to contamination of
grain by seeds of Heliotropium lasiocarpum and Tri-
chodesma incanum. In addition to several managerial
measures, a state standard was set for the quality of
grain stored for food. The limits of seeds of these two
weeds were set at 0.2% and zero, respectively (IPCS,
1988).
4.2.3. Cassa6a cyanogenic glucosides
No safety limits have been established for fresh cas-
sava roots, because the processing greatly influences the
toxicant levels at consumption. For cassava flour a
safety limit has been set by the Codex Alimentarius
Commission of the FAO:WHO at 10 mg HCN:kg
(CAC, 1991). The origin of this value is obscure. A
literature review on studies of cyanogen levels in cassava
products in Africa, indicated that none of the mean
concentrations met with this requirement, which sug-
gests that this limit is unrealistically low (Essers, 1998).
If strictly adhered to, most of African cassava flour
would probably be disqualified for consumption,
thereby creating a famine of unprecedented size.
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4.2.4. Glycyrrhizic acid in licorice
The critical effect of exposure to glycyrrhizic acid in
licorice is inhibition of the enzyme 11-hydroxysteroid
dehydrogenase which in turn leads to a syndrome of
apparent hypermineralo-corticoid excess. Based on case
reports and exposure of healthy volunteers, the Nordic
Working group of Food Toxicology and Risk Assess-
ment (NNT) established a provisional LOAEL of 100
mg:day for adults. It was recognised that symptoms
may occur at even lower intakes in very sensitive indi-
viduals (Størmer et al., 1993). Since the effect of gly-
cyrrhizic acid involves retention of sodium, a high
intake combined with a high sodium intake as in our
Western societies are probably not advisable. A recent
study of the intake in the Dutch population showed
that about 13% was regular users and the average
intake of glycyrrhizic acid among these was 11 mg:day
with a maximum of 188 mg. Of pregnant women 31%
were regular users with a mean intake of 13 mg:day, the
95 percentile being 45 mg:day (Hulshof and
Kistemaker, 1995). According to the guidelines of the
EU Scientific Committee for Food (SCF) the intake of
glycyrrhizic acid should not exceed 100 mg:day (Com-
mission of the European Communities, 1992). This
shows that the recommended maximum limit by the
EU SCF is set at the LOAEL with no safety margins.
Furthermore the safety margins of the high consumer
group are also small.
Clearly, the few safety limits and product require-
ments that have been set for inherent food plant toxi-
cants are not based on a NOAEL divided by an
uncertainty factor, but are either somewhat above the
maximal average ingestion (solanidine glycosides in
potatoes), the LOAEL (glycyrrhizic acid), or even unre-
alistically low and therefore without compliance or
effect (cyanogenic glucosides in cassava flour).
The legislation for the addition of new chemicals to
foods is based on the proof that they are safe, with a
sufficient safety margin to exclude any appreciable risk.
In the case of inherent food plant toxicants in tradi-
tional foods, the substances are not new or alien to
humans and so the effects, although possibly undesired
or yet unknown, may not constitute new health hazards
of an unknown magnitude. The safety testing of new
chemicals prior to their approval, are designed to en-
sure that false negative results (when a substance is
wrongly thought to be safe but in fact it is not) are
excluded; that is, over-regulation is safer than under-
regulation. With traditional foods which contain inher-
ent food plant toxicants for which there is a history of
apparently safe use, false positives (when a substance is
wrongly thought to cause harm or risk of harm, but in
fact it does not) should be avoided. Exceptions exist for
proven highly toxic substances like pyrrolizidine alka-
loids. It is widely accepted that the higher the suspected
toxicity, and the more serious the effect, the less proof
that is necessary before taking regulatory steps.
For the tolerance of long established foods with
inherent toxicants, we suggest that the approach should
therefore be the other way around to that outlined
above: Enough evidence should be gathered to prove
that the food product including that substance at a
certain intake level gives rise to toxic effects, before
regulation is effected which may endanger the produc-
tion, trade or consumption of current products. The
question of what is ‘enough evidence’ then becomes the
crucial issue, to be judged by expert committees.
5. Risk estimation of inherent food plant toxicants
To assess the risk of inherent food plant toxicants, a
number of aspects which are more or less characteristic
to these food plants, has to be taken into consideration.
5.1. Incorporating human experience
How can the history of virtually or apparently safe
use be incorporated in risk assessment? Information on
consumer morbidity and mortality associated with the
use of the product could be related to the number of
years that the product has been used, the number of
people that consume the product regularly, the
availability and outcome of medical and epidemiologi-
cal data and, where possible, linked with the levels of
the toxicant at the moment of safe consumption and of
toxic effects. A ‘human experience factor’ might possi-
bly be expressed quantitatively and used as an alterna-
tive to the uncertainty factor for the human
heterogeneity. The logic behind this is that the more
people who have used the product without ill effects for
a longer time, and the better this has been studied, the
lower the uncertainty factor. The viability of this con-
cept should be examined and illustrated by examples. A
first effort to apply it to solanum glycoalkaloids did not
lead to useful results for the following reasons:
1. Cases of known poisonings were often due to un-
usual circumstances, such as consumption of peel,
sprouts, immature or green potatoes;
2. Detailed exposure data on quantity and kind of
glycoalkaloids were usually lacking;
3. It is not known which part of common gastro-intes-
tinal disturbances in the population are related to
potato consumption.
Another option is not to integrate this information as
a factor in a formula based on toxicological studies, but
to keep it separate next to the calculated risk, and
balance them, as has been done so far implicitly. The
criticism of ad hoc or even post hoc regulation would
not be obviated unless this balancing is made according
to clearly defined rules. However, it is not yet clear if
uniform rules will be applicable in a meaningful and
exhaustive way. Therefore, examples are necessary.
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Fig. 1. A test system for risk management of plant foods with inherent toxicants.
Apart from using general human experience, detailed
epidemiological studies and toxicological testing remain
necessary for suspected food constituents. No single test
system provides sufficient information either to describe
the health characteristics or to assess the risk of an
inherent food plant toxicant. A combination of tests is
necessary, including tests of the single substance under
study, as well as the whole foodstuff which contains the
toxicant(s). This approach is visualised in Fig. 1.
The kind of the initial research depends on whether it
is triggered by health effects in the population, by
concern on properties of a chemical or the food, and on
the available data, and the kind and severity of the
toxic response.
For example, in cases of population concern from
reported health effects associated with consumption of
a foodstuff, it is logical to start research by studies on
the consumption pattern of the foodstuff associated
with health problems, possibly followed by (animal)
toxicity testing of the whole food. Another route may
be the identification of the toxicant, estimation of its
concentration in foodstuff and toxicity testing of the
pure substance followed by estimation of health risk
based on food consumption and toxicity of the pure
compound. Comparison between the toxicity of the
foodstuff and the pure compound results in establish-
ment of the product correction factor (PCF).
A third route contributing to the estimation of health
risk comprises epidemiological studies, including iden-
tification of risk groups.
The relationship between toxicity of the pure sub-
stance and that of the whole foodstuff in animals and
humans is described in paragraphs 5.3 and 5.4 and
visualised in Fig. 2.
5.2. Whole foodstuff testing
The critical issue in risk assessment is the toxicity of
the whole diet in relation to the susceptibility of the
consumer. As consumers compose their diet of different
foodstuffs, which therefore may appear in different
combinations, the basic unit to test for toxicity is the
processed and prepared whole foodstuff. It implies an
intrinsic balancing of the amount of toxic substances
and of factors modifying the toxic responses, such as
matrix and interacting constituents2. It can be achieved
by substituting part of the diet by the food to be tested,
and compensating for energy and (micro-)nutrients.
The proportion of the food in the diet then depends on
its usual place in the diet, e.g. for potatoes this might
2 This corresponds with the EPA Guidelines for the Health Risk
Assessment of Chemical Mixtures (1986), which states that the car-
cinogenic effects of a mixture can best be examined by testing the
mixture.
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Fig. 2. A scheme of animal and human testing, arranged as an interactive grid for assessing the relationship between the toxicity of pure substances
and that of the whole food in which the substances occur. Indicated is the relevance of the data and the feasibility of obtaining them.
range up to 60% energy, for leafy vegetables up to 10
g:kg body weight, and for black pepper up to some 300
mg:kg body weight. An example of this approach is the
study of the long-term wholesomeness of autoclaved or
irradiated pork in rats by Van Logten et al. (1983), in
which 35 w:w % of the diet was replaced with treated
pork. Another example can be seen in the chronic
studies with complete human diets in rats by Alink et
al. (1989, 1993). The diets were composed according to
mean consumption figures in the Netherlands.
Experimental studies with human volunteers are es-
pecially relevant and because the toxicants and the food
are not new or alien, such studies do not raise signifi-
cant problems for ethical considerations. Studies using
human volunteers have the advantage that no extrapo-
lation from animals to humans is necessary and that
certain aspects can be investigated, such as the effects
on higher brain functions (mood, headache), which
cannot be studied in animals. Toxicokinetics can be
studied also and then compared with those from animal
models.
Epidemiological studies among humans can consist
of observational studies relating exposure (intake levels
or biomarkers of exposure) to health effects (e.g. case-
control or cohort studies), and of randomised con-
trolled trials that are used for testing potentially
beneficial foods or ingredients on disease endpoints.
Examples are the b-carotene and lung cancer trial in
Finland, and the US Women’s Health Trial on effect of
fat reduction and increased vegetables:fruit consump-
tion on breast cancer. However, randomised controlled
trials using hard disease endpoints with potential toxi-
cants are not feasible or ethical. In those instances, in
humans only studies with biomarkers of exposure and
effect, as well as reversible physiological effects, are
feasible. The development and use of biomarkers is
crucial to increase the sensitivity of the human and
animal assays.
Historically, the selection of plants for human con-
sumption has been based on the safety of the whole
plant food. If the plant was found to be toxic, it might
still have been consumed if adequate processing elimi-
nated or deactivated the toxic factor. During the devel-
opment of toxicology, emphasis was put on isolation,
characterisation and quantification of the toxic princi-
ple and dose:effect relationships. This is still important.
However, for inherent toxicants in plant foods not only
does the toxic principle and its dose determine the
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toxicity, but other food factors can alter the
bioavailability of the reactive metabolite or give rise to
interactions such as synergism and antagonism. There-
fore, the toxic effect of the whole foodstuff has to be
taken into account.
5.3. Toxicity characterisation
Ideally the whole foodstuff should be tested in both
animal and human subjects. In practice this will not
always be possible. Thus the amount of the whole
foodstuff that can be consumed by experimental animals
is constrained by the need to feed nutritionally balanced
diets and the concentration of the toxicant in the foodstuff
may be too low to induce adverse effects in animals. In
feeding trials with human subjects the possible conse-
quences of the toxicity may prevent experimental testing.
A solution to this problem is to organise the vari-
ables characterising toxicity into a grid in which their
inter-relationships are displayed. The incorporation of
appropriate data into this grid allows a quantified
assessment to be made of the probable range of the
toxic effect of the foodstuff on human subjects. The
grid for toxicity characterisation is shown in Fig. 2.
The grid is formed from two strata, animal and
human studies interacting with the degree of exposure
and the magnitude of the effect. Each stratum consists
of two parts, the pure substance and the whole food-
stuff, described as the product. The evaluation of toxic-
ity of a foodstuff progresses across the grid from left to
right. The direction is from the most readily established
data with the isolated toxicant in animals towards the
determination of the toxicity of the whole foodstuff, the
product, in humans.
The pure substance and the foodstuff in which it
occurs, the product, are each evaluated in animals and
humans so far as ethical and practical constraints per-
mit. Progressing across the grid, the challenges are to
establish a measure of exposure and to observe, define
and quantify the toxic effect.
Direct quantification of the toxic effect of the food-
contained toxicant may not be possible, even in ani-
mals, and consequently markers of exposure and of
effect are used.
Biomarkers may be:
1. Exposure biomarkers, which relate the internal dose,
or target organ dose, to the external dose and are
specific for that chemical and animal model.
2. Effect biomarkers, which relate the effect, or a sur-
rogate endpoint, to the external dose, and may be
either specific to the chemical or non-specific.
3. Susceptibility biomarkers, which relate to the differ-
ences in susceptibility of exposed individuals, for
example a genetic polymorphism. Such biomarkers
are of greatest value in interpretation of epidemio-
logical studies.
The degree of uncertainty associated with the final
evaluation of the toxicity of the product is least when
the greatest number of the possible considerations in
the grid have been taken into account.
There are many risk assessment scenarios. For exam-
ple, the toxic effect may have been established with the
isolated toxicant in the animal studies, while it may not
be possible to feed sufficient quantity of the product to
achieve a toxic effect. Risk assessment is possible
providing that exposure to the product has been defined
and its effect monitored through biomarkers. The use
of biomarkers of exposure makes it possible to predict
the extent of any adverse toxic effect of the product in
the animal.
The quality of this quantified prediction is primarily
dependent on the quality of the experimental data. The
use of the data is enhanced by the selection of appropri-
ate sections of the grid for interaction, and by quantify-
ing the interaction by the establishment of ratios.
The following factors for the risk estimate of inherent
food plant toxicants are proposed: product correction
factor (PCF), relating data on the product (food) to the
pure chemical within the animal stratum or within the
human stratum; and human-animal biomarker ratio
(HABR) to interrelate the animal and human strata.
These factors are described below.
5.4. Product correction factor
Each of the animal and human sets of data (Fig. 2)
includes assessments of the toxicant in isolation and of
the foodstuff containing the toxicant. The comparison
of biomarkers of exposure and:or for effect of the
food-contained toxicant and for the toxicant in pure
form is considered fundamental in this approach. In
this way, the alterations in toxicity due to the foodstuff
will be evident. The comparison of foodstuff and iso-
lated toxicant can be combined to provide a correction
factor. The correction factor is a property of the food-
stuff that quantifies its capacity to modify the response
to the toxicant. We call this factor the ‘product correc-
tion factor’ (PCF). It is determined by the ratio of the
quantity of the food-contained substance and the quan-
tity of the pure substance which gives rise to the same
biomarker and:or toxic effect in the same animal model
or in humans.
PCF
dose:effectphytotoxin food
dose:effectpure phytotoxin
Depending on dose level, choice of effect and severity
of effect, the PCF may vary. The displacement and the
steepness of the curve for the food-contained toxicant
(with respect to the curve of the pure chemical) describe
the capacity of the whole foodstuff to modify the toxic
response and will depend on the foodstuff composition.
It is possible that the dose-effect curves for the pure
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substance and for the whole food product do not run
parallel. This may occur, if a low toxicant level is
completely neutralised by other constituents in the
food, while a high concentration of toxicant in the food
is only partially neutralised by the then limited amount
of other constituents. The possible complex character of
this quotient is exemplified in Fig. 3. The relevant PCF
then is the ratio of values of the curve which relate to
the highest no-effect level or to the highest actual
product and uptake levels.
The effect:dose may be the LOAEL or the NOAEL
or, if toxicological effects cannot be elicited, the critical
biomarker may be taken as an effect. In a simplified
approach, the factor can be defined as the ratio of the
LOAEL of the substance in food to the LOAEL of the
pure substance:
PCF
LOAEL phytotoxin food
LOAEL pure phytotoxin
The PCF is 1 if there is no additional net effect of the
foodstuff; the PCF is B1 if there is synergism or
addition between the toxic substance and other sub-
stances; the PCF is \1 if the food contains health
protecting principles which diminish the effect of the
toxic principle. This may be due to altered bioavailabil-
ity (e.g. matrix effects) or interaction with other sub-
stances (e.g. antioxidants) at the toxicokinetic or
toxicodynamic phase resulting in protective effects.
If a toxic effect cannot be elicited in the whole-food-
stuff experiment, a specific biomarker, related to the
toxic action of the substance can be used as an end-
point. It is recognised that a suitable biomarker of
effect may not be available especially to predict chronic
toxicity. Biomarkers of exposure are in principle easier
to be measured and can be used to detect possible
changes in bioavailability and possible metabolism of
the chemical due to the other food constituents. It is
important to obtain mechanistic information from ani-
mal experiments and in vitro studies in order to identify
suitable biomarkers and to improve the interpretation
of experimental results. It is also important to conduct
animal and human studies to assess the predictive abil-
ity of biomarkers regarding hard disease endpoints, so
as to define their suitability.
Knowing this relationship makes the use of a wide
range of techniques and data possible: a small database
of foodstuffs can be linked to a larger database of pure
substances. This enables predictions to be made for
other constituents in the same foodstuff and for similar
constituents in other foodstuffs. The PCF will be a tool
for risk managers to apply the information developed
for toxicants in isolation to food-contained toxicants. It
may provide information for food industries to further
reduce risks from inherent food plant toxicants.
5.5. Animal to human extrapolation
Observations of toxic effects in humans, related to a
specific toxicant in food, are often not available and it
is not possible or desirable to induce toxic effects with
experimental feeding of the whole foodstuff, in humans.
In the absence of human effect data, interspecies com-
parisons can be made on the basis of selected biomark-
ers. A similar mechanism of toxicity must be presumed
in animals and humans, but this is inherent to any risk
assessment based on animal studies.
For the comparison of biomarker levels in animals
and humans we propose the term ‘human-animal
biomarker ratio’ (HABR). The HABR is the ratio of
the dose-related biomarker levels in humans and in
animals. Ideally, specific effect biomarkers should be
used to derive HABR’s, but if this is not possible,
biomarkers of exposure may yield some useful informa-
tion for the extrapolation from animals to humans.
Extrapolation to estimate toxic levels in humans may
be feasible, based on the data observed from the animal
model representing an extended dose-range and from
the human studies obtained at relatively low dose
ranges where only changes in biomarkers would be
observed. This extrapolation is only valid if the animal
and human response curves are assumed to be similar.
Depending on the type of association between the
selected biomarker and the predicted toxic effects, a
margin of uncertainty may exist.
Fig. 3. Possible (hypothetical) dose:response curves for pure (2) and
food-contained inherent (1,3,4) toxicants 1) Food contained toxicant.
PCFB1 due to synergism from the food, or inhibition of detoxifica-
tion in the body. 2) Pure toxicant. 3) Food contained toxicant.
PCF\1 due to antagonism from the food, or inhibition of activation
in the body. 4) Food contained toxicant. PCF\1 due to dose
dependent interaction or saturation of metabolism. The Product
Correction Factor (PCF) is the ratio of a dose at a given response in
curve 1, 3 or 4, divided by the dose of curve 2 at the same response.
Only the lower part of the curve (up to the LOAEL) is of interest.
Although curve 4 does not parallel that of the pure compound, the
PCF can still be established as e.g. X4: X2.
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HumanAnimal Biomarker Ratio
[Bh ]:Dose h
[Ba ]:Dose a
[Bh ]Biomarker’s level in humans (e.g. in nmol:ml
serum).[Ba ]Biomarker’s level in animals (in same
units).Dose hdose of substance (e.g. in mg:kg body
weight), in humans.Dose adose of substance (in same
units), in animal model.
5.6. Risk assessment of inherent food plant toxicants
requires epidemiology as well as toxicology
Toxicological tests are necessary for a proper assess-
ment of inherent toxicity of food products, They may
elucidate whether a product is as safe as presumed,
identify toxic responses, discern the toxic constituents,
discover dose-effect relationships, and establish kinetics
and mechanisms of action. Experimental toxicology is
very useful for the prediction of potential health haz-
ards. With the testing of pure chemicals the test dose
can be increased by a factor ten or more to provoke,
reveal or enhance any effect and to trigger certain
effects in a larger group of the test population. We have
already discussed that it is necessary to test not only the
pure substance, but also the whole foodstuff. However,
levels of inherent food plant toxicants in common
human food items are, in general, below those which
cause observable adverse effects. Toxicological testing
of inherent food plant toxicants at such low doses in
groups of animals or humans may not yield useful
information, whilst at the human population level such
doses might still lead to toxic effects which are very
mild, occur after some time or which have a low
statistical probability or incidence, such as cancer and
allergenicity. If the highest possible physiological intake
levels of the whole foodstuff are close to the levels
actually consumed, as with staple foods, then experi-
mental tests with human volunteers will not cover the
heterogeneity of the whole population with regard to
human susceptibility and diet.
As discussed earlier, using an uncertainty factor to
bridge the gap between studies with a small number of
humans and a human population at large would be
inappropriate. Vainio et al. (1990) (IARC) concluded
that the most relevant quantitative data for making risk
estimates for complex mixtures come from epidemio-
logic studies of populations exposed to the complete
mixture.
Bearing in mind the adverse effects of the pure
substance found in toxicological tests, cases of poison-
ing in the past, if available, and different populations
consuming different quantities of the food and the
toxicant should be investigated to assess possible rela-
tionships with their health status and health history.
From such data it may be possible to derive levels of
‘apparently safe’ use and thus include the human expe-
rience to complement toxicological evidence. So, in case
of inherent food plant toxicants which rarely give rise
to toxic effects or only to very mild effects in humans,
we also have to rely on epidemiological data for a
proper risk assessment.
Basing assessments on epidemiological data is not
new. The National Health Council of The Netherlands
(1985) and the JECFA (IPCS, 1987) differentiate be-
tween ADI values on the basis of experimental animal
studies (in which a safety factor of 100 is used) and
based on epidemiologic data of oral intake (to which a
safety factor of 10 is applied). The National Health
Council of The Netherlands (1994) states that for the
risk assessment of carcinogens adequate epidemiologi-
cal data should prevail over animal data; it adds,
however, that such solid data are rare. In occupational
risk assessment, where relatively well defined conditions
prevail and effects are known, it is common that the
human experience data are used as the departure point
for risk assessment.
However, epidemiological studies frequently suffer
from imprecise characterisation of exposure and:or
health effects. Also, the number of confounding factors
in assessing the health implications of common foods in
a population can be large, and risk assessment is usu-
ally based on toxicological studies, although these suf-
fer from the problems of high to low dose extrapolation
and species extrapolation from animals to humans.
Therefore: epidemiological studies may be important
in determining whether a toxic constituent produces
adverse effects in human reality, while toxicological
tests are necessary for assessing which effects might
occur (hazard identification) and mechanisms of toxic-
ity. Together epidemiological and toxicological studies
may reveal whether health effects found at the popula-
tion level are likely to be caused by a certain foodstuff
or constituent of it. The use and integration of several
disciplines is essential for the risk assessment of inher-
ent food plant toxicants in traditional products (Table
1): Usually, there is first some evidence that toxic
effects are possibly related to a food product or a food
constituent from clinical reports on cases of poisoning
(medical case studies), possibly followed up by observa-
tional population studies. This may trigger both experi-
mental toxicological and epidemiological studies. The
use of biomarker-based epidemiological studies may
prove to be of particular importance. Studies in other
disciplines are necessary for understanding the condi-
tions which may lead to toxic effects, for measuring the
toxicant and for developing techniques to reduce or
control the risks.
An example of this multidisciplinary approach is the
research on the outbreak of an unknown paralytic
disease ‘konzo’ in a rural area in Mozambique. A large
epidemiological survey was carried out, which included
physical, neurological and nutritional parameters (Min-
istry of Health of Mozambique, 1984). This research
A.J.A. Essers et al. : En6ironmental Toxicology and Pharmacology 5 (1998) 155–172 169
Table 1
Disciplines involved in risk assessment on intrinsic plant food toxi-
cants
Toxicological testing of the (suspected) pure component
Assess whether the effect found in humans can be repeated
experimentally;
Assess possible toxic effects, the critical effect, and establish a
dose-effect relationship;
Assess the mechanisms of the toxic action;
Assess exposure and effect biomarkers;
Assess the possible kinetics and bioavailability of the pure
substance (absorption, resorption, distribution,
biotransformation and elimination).
Toxicological testing of the integral food product
Compare the results of the kinetics, toxic effects and dose-effect
relationship with those found for the pure component.
Exposure and intake assessment
Qualitatively and quantitatively assess the relevant (toxic)
constituents, localization in the product, their stability etc. and
the effect of different processing techniques.
Assess in the population the consumption of the foodstuff and
calculate the intake of the constituent in different categories of
consumers.
Identify agronomic factors that influence phytotoxin levels.
Epidemiology and case reports
Problem signalizing: Information from population studies and
case studies. Epidemiology can play a role especially in
identifying the chronic, cumulative and teratogenic effects, and
minor acute or semi chronic effects which have a low statistic
probability. Detailed studies may point to either whole
foodstuffs or constituents.
Verifying in the population certain effects found in toxicological
experiments.
Establishing the magnitude of a toxicity problem.
Assess the adverse health effects as well as the nutritional benefits
of the foodstuff.
Estimate the history of safe use and toxic effects in the past and
describe it in terms of ‘human experience’, also indicating
vulnerable categories of consumers.
These steps do not necessarily have to be followed in the order given,
and often show a cyclic sequence: advances in one discipline provoke
more refined research in another.
Animal experiments have yet to be undertaken to
provide evidence that the paralytic disease can be elic-
ited experimentally, to show which metabolic routes
and which co-factors are essential, and to elucidate the
mechanisms leading to the neurological damage. Addi-
tional studies on cyanogen exposure and (absence of)
health effects in cassava consuming populations may
lead to realistic risk estimates.
5.7. Establishing priorities for future study
Establishing priorities for deciding which inherent
food plant toxicants to study should be based on the
severity of the (estimated) health risk involved, the
extent and intensity of human exposure; other common
criteria include the feasibility of obtaining useful re-
sults. For risk management and regulation the possibil-
ities of minimising the risk and the related economic
burden for society is also taken into account. The
predicted population burden of the health hazard is a
product of the actual or potential health effect, expo-
sure (actual or expected consumption and uptake levels
and forms) and the number and demography of those
exposed. As the actual effect of certain inherent food
plant toxicants on human health is usually unknown
when priorities are established, hypothetical extrapola-
tions on the basis of known or expected effects can be
useful, e.g. when a toxicant resembles or is part of a
group of known toxicants. In novel foods, certain
suspected chemicals may be in higher concentrations
than usual, or new entities might be formed, or the
concentrations of neutralising factors may be reduced,
which may lead to research priority.
An obvious and essential criterion for establishing
priority in research where each of these considerations
is concerned is that there is insufficient experimental
data or a lack of adequate risk evaluation.
The development of relevant scientific data, such as
bioavailability, Pharmacologically Based Pharmaco Ki-
netic (PB-PK) modelling, mechanistic data and PCF, is
important for the development of scientifically defensi-
ble risk assessments. This applies equally to the tradi-
tional approaches (for example replacing default
uncertainty factors by data-derived values for threshold
effects and PB-PK modelling of target organ doses for
genotoxic carcinogens) and to the procedures for inher-
ent food plant toxicants described in this paper. In the
absence of appropriate data, risk assessments normally
adopt conservative procedures. The characterisation of
a clear health benefit of the foodstuff should be the
rationale for the adoption of a risk assessment which is
less conservative than the safety evaluation which
would be applied to a food additive or environmental
contaminant.
was later extended to several other geographical areas.
These studies identified, described and defined the dis-
ease; a statistical relationship with cyanide exposure
from the consumption of insufficiently processed cas-
sava roots of high cyanogenic varieties was shown
(Howlett et al., 1992; Tylleska¨r, 1994), and factors that
had led to this consumption and the insufficient pro-
cessing were revealed (Ministry of Health of Mozam-
bique, 1984; Essers et al., 1992). Animal studies had
shown the metabolic routes of the toxicant. Assessment
of the toxicants in the food and extremely elevated
levels of their exposure biomarkers in new konzo vic-
tims and not in controls further supported a causative
role of the toxicant (Rosling, 1994). Feeding studies
with human volunteers subsequently yielded some in-
formation on the kinetics of the food-contained toxi-
cants in humans (Carlsson et al., 1995).
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6. Recommendations
In the light of the small safety margins for many
inherent toxicants in plant food, there is a need for
more accurate risk assessments of these substances in
food. There is very little data on these substances. In
order to perform such risk assessments, more data will
be needed.
It is necessary to establish an information system
(data base) containing critically assessed data on com-
position and toxicological potential of inherent toxi-
cants and protective factors in food plants and products
thereof.
For risk assessment of inherent food plant toxicants,
it is essential to consider the whole foodstuff and to
take into account the action of protective factors and
possible interactions between the various food
constituents.
Data on adverse effects and biomarkers of effect and
exposure are necessary for risk assessment of inherent
food plant toxicants.
The procedure proposed here for risk assessment of
inherent food plant toxicants, allows the combination
of data from animal and human studies to provide a
scientifically based risk assessment.
Adoption of the procedures described in this paper
represents an important step in the establishment of
scientifically based risk assessment for inherent food
plant toxicants.
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